Millennium Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.14M Buy
594,031
+170,446
+40% +$2.34M ﹤0.01% 1767
2025
Q1
$4.68M Sell
423,585
-222,200
-34% -$2.46M ﹤0.01% 2017
2024
Q4
$6.88M Sell
645,785
-853,416
-57% -$9.09M ﹤0.01% 1807
2024
Q3
$19M Buy
1,499,201
+338,302
+29% +$4.3M 0.01% 1133
2024
Q2
$19.5M Buy
1,160,899
+1,119,019
+2,672% +$18.8M 0.01% 1087
2024
Q1
$628K Sell
41,880
-384,626
-90% -$5.77M ﹤0.01% 3194
2023
Q4
$6.4M Buy
426,506
+150,721
+55% +$2.26M ﹤0.01% 1750
2023
Q3
$3.86M Buy
275,785
+83,657
+44% +$1.17M ﹤0.01% 2069
2023
Q2
$1.99M Sell
192,128
-162,648
-46% -$1.68M ﹤0.01% 2529
2023
Q1
$3.28M Buy
354,776
+77,528
+28% +$716K ﹤0.01% 2195
2022
Q4
$2.46M Sell
277,248
-162,274
-37% -$1.44M ﹤0.01% 2577
2022
Q3
$3.66M Sell
439,522
-176,723
-29% -$1.47M ﹤0.01% 2421
2022
Q2
$5.05M Buy
616,245
+459,341
+293% +$3.76M ﹤0.01% 2155
2022
Q1
$1.37M Buy
156,904
+89,412
+132% +$779K ﹤0.01% 3349
2021
Q4
$642K Sell
67,492
-1,195
-2% -$11.4K ﹤0.01% 3827
2021
Q3
$1.16M Buy
68,687
+4,887
+8% +$82.2K ﹤0.01% 3509
2021
Q2
$974K Sell
63,800
-10,401
-14% -$159K ﹤0.01% 3744
2021
Q1
$1.45M Buy
74,201
+2,679
+4% +$52.2K ﹤0.01% 3024
2020
Q4
$1.29M Sell
71,522
-18,186
-20% -$328K ﹤0.01% 2763
2020
Q3
$1.73K Sell
89,708
-16,571
-16% -$320 ﹤0.01% 2130
2020
Q2
$2.78M Buy
+106,279
New +$2.78M ﹤0.01% 1819
2019
Q4
Sell
-10,855
Closed -$258K 3815
2019
Q3
$258K Sell
10,855
-79,513
-88% -$1.89M ﹤0.01% 3025
2019
Q2
$3.25M Sell
90,368
-9,526
-10% -$342K ﹤0.01% 1764
2019
Q1
$3.69M Sell
99,894
-9,998
-9% -$369K 0.01% 1666
2018
Q4
$4.73M Sell
109,892
-123,461
-53% -$5.32M 0.01% 1457
2018
Q3
$11M Buy
233,353
+61,021
+35% +$2.88M 0.01% 1128
2018
Q2
$8.58M Buy
172,332
+13,219
+8% +$658K 0.01% 1294
2018
Q1
$7.91M Buy
159,113
+147,628
+1,285% +$7.34M 0.01% 1412
2017
Q4
$427K Buy
+11,485
New +$427K ﹤0.01% 2946